A detailed history of Wcm Investment Management, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Wcm Investment Management, LLC holds 286,527 shares of ACAD stock, worth $4.69 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
286,527
Previous 289,417 1.0%
Holding current value
$4.69 Million
Previous $4.7 Million 6.25%
% of portfolio
0.01%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$15.14 - $19.14 $43,754 - $55,314
-2,890 Reduced 1.0%
286,527 $4.41 Million
Q2 2024

Jul 31, 2024

BUY
$14.62 - $18.42 $107,924 - $135,976
7,382 Added 2.62%
289,417 $4.7 Million
Q1 2024

Apr 25, 2024

BUY
$17.79 - $30.86 $5.02 Million - $8.7 Million
282,035 New
282,035 $5.21 Million
Q2 2021

Aug 05, 2021

SELL
$19.4 - $27.42 $2.52 Million - $3.56 Million
-129,864 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$25.02 - $54.99 $1.41 Million - $3.1 Million
56,330 Added 76.6%
129,864 $3.35 Million
Q4 2020

Feb 16, 2021

BUY
$41.04 - $56.79 $17,031 - $23,567
415 Added 0.57%
73,534 $3.93 Million
Q3 2020

Nov 06, 2020

BUY
$36.42 - $57.0 $121,970 - $190,893
3,349 Added 4.8%
73,119 $3.02 Million
Q2 2020

Aug 18, 2020

SELL
$39.26 - $52.73 $1.1 Million - $1.47 Million
-27,891 Reduced 28.56%
69,770 $3.38 Million
Q1 2020

May 08, 2020

BUY
$31.65 - $46.87 $893,637 - $1.32 Million
28,235 Added 40.67%
97,661 $4.13 Million
Q4 2019

Feb 07, 2020

BUY
$36.21 - $51.4 $2.05 Million - $2.92 Million
56,750 Added 447.7%
69,426 $2.97 Million
Q3 2019

Oct 25, 2019

BUY
$22.22 - $44.01 $281,660 - $557,870
12,676 New
12,676 $456,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.65B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Wcm Investment Management, LLC Portfolio

Follow Wcm Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wcm Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wcm Investment Management, LLC with notifications on news.